<DOC>
	<DOCNO>NCT03077620</DOCNO>
	<brief_summary>The purpose study change concentration amyloid-beta human cerebrospinal fluid ( CSF ) modification sleep efficiency .</brief_summary>
	<brief_title>Sleep Quality Amyloid-Beta Kinetics</brief_title>
	<detailed_description>The purpose study investigate whether increase sleep efficiency change concentration amyloid-beta cerebrospinal fluid ( CSF ) .</detailed_description>
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Suvorexant</mesh_term>
	<criteria>Age 4565 year Any sex Any race/ethnicity MiniMental Status Examination score ( MMSE ) &gt; =27 Insomnia Severity Index &lt; 8 Sleep efficiency measure actigraphy determine good sleeper poor sleeper Cognitive impairment determine history MMSE &lt; 27 Inability speak understand English BMI &gt; 35 Any sleep disorder insomnia history sleepdisordered breathing STOPBang score &gt; 2 History report symptom suggestive restless legs syndrome , narcolepsy sleep disorder Sleep schedule outside range bedtime 8PM12AM wake time 4AM8AM Contraindication lumbar catheter ( anticoagulant ; bleed disorder ; allergy lidocaine disinfectant ; prior central nervous system lower back surgery ) Cardiovascular disease require medication except control hypertension Stroke Hepatic renal impairment Pulmonary disease Diabetes Neurologic psychiatric disorder require medication Alcohol tobacco use ( PI discretion ) Use sedate medication Inability get bed independently Abnormal movement nondominant arm ( would affect actigraphy data unpredictable way ) Abnormal physical examination Current pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>